The aim of this prospective cohort study was to investigate the multi-omics characteristics of the efficacy of colchicine treatment in patients with ACS and to construct a model of efficacy. The main questions the study aims to answer are
\- Specific mechanisms of colchicine therapy in patients with ACS; Mechanism-based modelling to identify the population that benefits from colchicine treatment.
Between the ages of 18 and 80
ACS (STEMI or NSTE-ACS)
Patients to receive standardised drug therapy
Able and willing to provide informed consent
Any contraindication to colchicine or known intolerance to colchicine
Has been using colchicine for a prolonged period of time for other medical conditions
Women of childbearing age who are pregnant, breastfeeding or not using effective contraception
Coronary artery bypass grafting within the last 3 years or planned